These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 36842415)

  • 1. Structure-based drug design with geometric deep learning.
    Isert C; Atz K; Schneider G
    Curr Opin Struct Biol; 2023 Apr; 79():102548. PubMed ID: 36842415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Data Integration Using Advances in Machine Learning in Drug Discovery and Molecular Biology.
    Hudson IL
    Methods Mol Biol; 2021; 2190():167-184. PubMed ID: 32804365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Progress of Deep Learning in Drug Discovery.
    Wang F; Diao X; Chang S; Xu L
    Curr Pharm Des; 2021; 27(17):2088-2096. PubMed ID: 33511933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery.
    Yang X; Wang Y; Byrne R; Schneider G; Yang S
    Chem Rev; 2019 Sep; 119(18):10520-10594. PubMed ID: 31294972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A compact review of progress and prospects of deep learning in drug discovery.
    Li H; Zou L; Kowah JAH; He D; Liu Z; Ding X; Wen H; Wang L; Yuan M; Liu X
    J Mol Model; 2023 Mar; 29(4):117. PubMed ID: 36976427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Geometric deep learning methods and applications in 3D structure-based drug design.
    Bai Q; Xu T; Huang J; Pérez-Sánchez H
    Drug Discov Today; 2024 Jul; 29(7):104024. PubMed ID: 38759948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-Based Drug Discovery with Deep Learning.
    Özçelik R; van Tilborg D; Jiménez-Luna J; Grisoni F
    Chembiochem; 2023 Jul; 24(13):e202200776. PubMed ID: 37014633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A New Hybrid Neural Network Deep Learning Method for Protein-Ligand Binding Affinity Prediction and De Novo Drug Design.
    Limbu S; Dakshanamurthy S
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep Learning in Structure-Based Drug Design.
    Anighoro A
    Methods Mol Biol; 2022; 2390():261-271. PubMed ID: 34731473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine learning and AI-based approaches for bioactive ligand discovery and GPCR-ligand recognition.
    Raschka S; Kaufman B
    Methods; 2020 Aug; 180():89-110. PubMed ID: 32645448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The power of deep learning to ligand-based novel drug discovery.
    Baskin II
    Expert Opin Drug Discov; 2020 Jul; 15(7):755-764. PubMed ID: 32228116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Machine Learning and Computational Chemistry for the Endocannabinoid System.
    Atz K; Guba W; Grether U; Schneider G
    Methods Mol Biol; 2023; 2576():477-493. PubMed ID: 36152211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep Learning Applied to Ligand-Based De Novo Drug Design.
    Palazzesi F; Pozzan A
    Methods Mol Biol; 2022; 2390():273-299. PubMed ID: 34731474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep learning and virtual drug screening.
    Carpenter KA; Cohen DS; Jarrell JT; Huang X
    Future Med Chem; 2018 Nov; 10(21):2557-2567. PubMed ID: 30288997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep Learning in Chemistry.
    Mater AC; Coote ML
    J Chem Inf Model; 2019 Jun; 59(6):2545-2559. PubMed ID: 31194543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HydraScreen: A Generalizable Structure-Based Deep Learning Approach to Drug Discovery.
    Prat A; Abdel Aty H; Bastas O; Kamuntavičius G; Paquet T; Norvaišas P; Gasparotto P; Tal R
    J Chem Inf Model; 2024 Aug; 64(15):5817-5831. PubMed ID: 39037942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generative chemistry: drug discovery with deep learning generative models.
    Bian Y; Xie XQ
    J Mol Model; 2021 Feb; 27(3):71. PubMed ID: 33543405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Structure-Based Drug Discovery Paradigm.
    Batool M; Ahmad B; Choi S
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31174387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent trends in artificial intelligence-driven identification and development of anti-neurodegenerative therapeutic agents.
    Kashyap K; Siddiqi MI
    Mol Divers; 2021 Aug; 25(3):1517-1539. PubMed ID: 34282519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of machine learning approaches for novel drug discovery.
    Lima AN; Philot EA; Trossini GH; Scott LP; Maltarollo VG; Honorio KM
    Expert Opin Drug Discov; 2016; 11(3):225-39. PubMed ID: 26814169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.